Venture Minerals Ltd (VMS):企業の財務・戦略的SWOT分析

◆英語タイトル:Venture Minerals Ltd (VMS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDNE61285FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Nuclear Energy
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥78,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥117,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venture Minerals Ltd (Venture Minerals) is a mining and mineral exploration company. It develops, discovers and explores mineral deposits. The company explores for Copper-Lead-Zinc, Nickel-Cobalt, Nickel-Copper and Nickel-Copper-Cobalt. Its project portfolio includes West Coast Projects, Tasmania, South West Projects, Caesar Project, Pingaring Project, and Golden Grove North Project. Its projects are located in Western Australia. Its west coast projects comprise Riley DSO Deposit, Mt Lindsay Tin-Tungsten Deposit, and Livingstone DSO Deposit. The company’s South West Projects comprise Thor Prospect, Base Metals and Odin Prospect, Lithium and Nickel-Copper. The company operates in Australia and South East Asia. Venture Minerals is headquartered in Perth, Western Australia, Australia.

Venture Minerals Ltd Key Recent Developments

Jan 08,2021: Venture Minerals completes trenching program at Kulin
Dec 02,2020: Venture Minerals : Drilling confirms VMS system with up to 7% zinc returned from first assays at Orcus prospect, Golden Grove North
Oct 16,2020: Venture Minerals: Drilling commenced on priority targets – Golden Grove North
Aug 27,2020: Venture Minerals: Dry screening operations commence at Riley Iron Ore Mine
Aug 06,2020: Venture Minerals: EM Survey unveils priority massive sulfide drill targets at Vulcan Copper-Gold Prospect

This comprehensive SWOT profile of Venture Minerals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Venture Minerals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Venture Minerals Ltd – Key Information
Venture Minerals Ltd – Overview
Venture Minerals Ltd – Key Employees
Venture Minerals Ltd – Key Employee Biographies
Venture Minerals Ltd – Key Operational Heads
Venture Minerals Ltd – Major Products and Services
Venture Minerals Ltd – History
Venture Minerals Ltd – Company Statement
Venture Minerals Ltd – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Venture Minerals Ltd – Business Description
Venture Minerals Ltd – Corporate Strategy
Venture Minerals Ltd – SWOT Analysis
SWOT Analysis – Overview
Venture Minerals Ltd – Strengths
Venture Minerals Ltd – Weaknesses
Venture Minerals Ltd – Opportunities
Venture Minerals Ltd – Threats
Venture Minerals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Venture Minerals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Venture Minerals Ltd, Key Information
Venture Minerals Ltd, Key Ratios
Venture Minerals Ltd, Share Data
Venture Minerals Ltd, Major Products and Services
Venture Minerals Ltd, History
Venture Minerals Ltd, Key Employees
Venture Minerals Ltd, Key Employee Biographies
Venture Minerals Ltd, Key Operational Heads
Venture Minerals Ltd, Other Locations
Venture Minerals Ltd, Subsidiaries

Venture Minerals Ltd, Key Competitors
Venture Minerals Ltd, SWOT Analysis
Venture Minerals Ltd, Ratios based on current share price
Venture Minerals Ltd, Annual Ratios
Venture Minerals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Venture Minerals Ltd (VMS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報
    Summary BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple …
  • Northwest Biotherapeutics Inc (NWBO):企業の財務・戦略的SWOT分析
    Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ohio State University Comprehensive Cancer Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University, is a healthcare institute that offers medical and academic education services. The institute provides education, research, and patient care services. Its services comprise cancer diagnosis, tre …
  • EMC Insurance Group Inc.:企業の戦略・SWOT・財務情報
    EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report Summary EMC Insurance Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Galliford Try Holdings Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Holdings Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析
    Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bloomberg L.P.:企業の戦略・SWOT・財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Afrimat Ltd:企業の戦略・SWOT・財務情報
    Afrimat Ltd - Strategy, SWOT and Corporate Finance Report Summary Afrimat Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Knight Therapeutics Inc (GUD):製薬・医療:M&Aディール及び事業提携情報
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used in the treatment of metabolic diseases, derma …
  • Zygo Corporation:企業の戦略的SWOT分析
    Zygo Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tsumura & Co.:企業の戦略・SWOT・財務分析
    Tsumura & Co. - Strategy, SWOT and Corporate Finance Report Summary Tsumura & Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SomaLogic Inc:医療機器:M&Aディール及び事業提携情報
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務分析
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Foundation for Innovative New Diagnostics-医療機器分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • OncoSec Medical Inc (ONCS)-医療機器分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Neurones SA (FR0004050250NRO):企業の財務・戦略的SWOT分析
    Neurones SA (FR0004050250NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆